Trial to assess H7N9 vaccine for humans

09/25/2013 | American City Business Journals · New Scientist

An Atlanta hospital and Emory University are testing a human vaccine for the H7N9 avian influenza virus that has sickened scores in China. The trial could provide an important tool for combating a possible pandemic, and it will also generate key knowledge about influenza vaccines generally, physician and Emory professor Mark Mulligan said. However, some experts argue production issues and other characteristics of influenza vaccination mean a vaccine would be inadequate for stemming a pandemic.

View Full Article in:

American City Business Journals · New Scientist

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ